EPIRUS Biopharmaceuticals, Inc (EPRS) - NASDAQ
From other sites
Company Description
EPIRUS Biopharmaceuticals, Inc. engages in the development and commercialization of biosimilar monoclonal antibodies. It develops a monoclonal antibody BOW015 which carries a brand name Remicade. The company operates its business through one operating segment: the development and... More
Sector: Healthcare
Industry: Biotechnology
Country: United States